Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence.

Source:http://linkedlifedata.com/resource/pubmed/id/21847123

Br. J. Cancer 2011 Sep 6 105 6 796-806

Download in:

View as

General Info

PMID
21847123